GLOBAL MARKET: CHINA STATE INSURERS, BANKS TO RAISE UP TO $54 BILLION TO BOLSTER CAPITAL

Eight Chinese state-owned insurance companies and banks will raise up to a combined $54 billion from shareholders, led by the Ministry of Finance, in a major effort to strengthen their capital buffers, Reuters reported.

The move comes as Beijing seeks to reinforce financial stability and give large state-owned institutions greater capacity to support the broader financial system.

Read more: Global Market: Japan's Nikkei falls 3% as oil surge, US rate hike fears weigh

Five insurers to receive up to $10.4 billion

Five state-owned insurers will receive up to 70 billion yuan ($10.4 billion) from the Ministry of Finance, which will issue special bonds to fund the capital injections. The move marks the first time China has used the mechanism to support insurers, Reuters said.

China Life Insurance Group, parent of the country's largest life insurer, will receive 35 billion yuan. China Taiping Insurance Group will receive 7 billion yuan, while China Export & Credit Insurance Corp, known as Sinosure, will receive 10 billion yuan.

PICC Group plans to raise up to 15 billion yuan through a private placement of A shares to the Ministry of Finance. China Reinsurance Group will raise up to 3 billion yuan.

The insurers said the new funds would be used to replenish capital and strengthen their ability to withstand financial risks.

Read more: Global Market Today: Asian stocks, bonds fall on oil, inflation concern

Falling bond yields add pressure

The capital injections come as falling long-term government bond yields have put pressure on insurers' core solvency ratios, limiting their ability to expand investments in equities.

Reuters reported that analysts see the fresh capital as helping insurers respond to Beijing's push for greater investment in the stock market while maintaining sufficient capital buffers.

China's insurers are also facing tougher solvency requirements that take full effect in 2026 following a transition period. The rules restrict the extent to which expected future policy profits and riskier assets, including unlisted equities and real estate, can be counted toward core capital.

Despite these pressures, the solvency positions of major state-owned insurers remain adequate and comfortably above regulatory minimums. Analysts therefore view the recapitalisation largely as a pre-emptive measure rather than a bailout.

Smaller insurers face greater pressure

The most significant capital and solvency challenges remain concentrated among smaller insurance companies.

The recapitalisation will improve the financial flexibility of large state-owned insurers and strengthen their ability to help maintain stability across the insurance sector, Fitch Ratings analyst Mengyuan Wang said, according to Reuters.

Large state insurers have also played an important role in helping resolve risks at troubled smaller insurers.

Equity investments unlikely to surge

The additional capital could ease restrictions on insurers' ability to invest in equities, but analysts do not expect a rapid or aggressive increase in stock-market allocations.

Reuters reported that JPMorgan analysts noted that the pace of growth in equity allocations by Chinese insurers slowed in the second quarter compared with the previous three months.

That suggests insurers have increasingly limited capacity to raise equity exposure further, the analysts said.

China has encouraged insurers to direct a larger portion of new premium income into equities, with a target of 30%. However, the major state insurers remain below that level.

At the end of June, stocks and funds accounted for 19.1% of China Life's 7.95 trillion yuan in investment assets, up from 16.9% at the end of 2025. The corresponding figures were 15.4% for PICC and 18.1% for China Taiping.

The recapitalisation is therefore expected to give China's large insurers more room to support equity markets and absorb financial risks, while tighter solvency rules and market volatility are likely to keep their investment strategies measured.

Disclaimer: The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here